Correction: Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy

Affiliations

¹ University of Leeds, Leeds, UK. m.e.booth@leeds.ac.uk.
² Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK.

Published Erratum

Mary E Booth et al. BioDrugs. 2022 Nov.

. 2022 Nov;36(6):791.

doi: 10.1007/s40259-022-00560-8.

¹ University of Leeds, Leeds, UK. m.e.booth@leeds.ac.uk.
² Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK.

No abstract available

Erratum for

Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy.
Booth ME, Smyth EC. Booth ME, et al. BioDrugs. 2022 Jul;36(4):473-485. doi: 10.1007/s40259-022-00527-9. Epub 2022 Apr 6. BioDrugs. 2022. PMID: 35384619 Review.